Grace Therapeutics, Inc. (GRCE) vs Nortech Systems Incorporated (NSYS)
A side-by-side comparison of Grace Therapeutics, Inc. and Nortech Systems Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GRCE
Grace Therapeutics, Inc.
$2.12HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
NSYS
Nortech Systems Incorporated
$11.37HealthcareDelayed quote: Oct 6, 2026, 2:16 PM EDT
Total return — GRCE vs NSYS
growth of $100 · dividends reinvested · last 2yGRCE -31.6% (-17.3%/yr)NSYS -8.3% (-4.2%/yr)NSYS compounded faster over this window
GRCE NSYS
GRCE vs NSYS: by the numbers
- •GRCE is the larger company ($35M vs $32M market cap).
- •NSYS is profitable (0.83% net margin) while GRCE runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | GRCE | NSYS |
|---|---|---|
| P/E ratio | N/A | 30.91 |
| P/S ratio | N/A | 0.25 |
| P/B ratio | 0.72 | 0.90 |
| EV / EBITDA | N/A | 12.91 |
| FCF yield | N/A | 6.08% |
Profitability
| Metric | GRCE | NSYS |
|---|---|---|
| Gross margin | 0.00% | 16.44% |
| Operating margin | 0.00% | 2.02% |
| Net margin | 0.00% | 0.83% |
| ROE | -44.50% | 2.91% |
| ROIC | -52.61% | 3.16% |
Growth (annualized)
| Metric | GRCE | NSYS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 4.00% |
| Total return CAGR (5Y) | N/A | -1.64% |
Frequently asked
- Is GRCE or NSYS more profitable?
- NSYS runs the higher net margin — GRCE at 0.00% versus NSYS at 0.83%.
Go deeper
Dig into the metrics
Nortech Systems P/E ratioGrace Therapeutics ROENortech Systems ROEGrace Therapeutics operating marginNortech Systems operating marginGrace Therapeutics revenue growthNortech Systems revenue growthGrace Therapeutics free cash flowNortech Systems free cash flow
Grace Therapeutics & Nortech Systems appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.